Ihr Suchergebnis
Sie recherchieren derzeit unangemeldet.Melden Sie sich an (Login) um den vollen Funktionsumfang der Datenbank nutzen zu können.
In der Rubrik News haben wir 19830 Angebote für Sie gefunden
-
Neue Erkenntnisse zur T-Zell-Erschöpfung
24.04.2025Auch bei unkomplizierten Infektionen stellt der Körper sich schon zu Krankheitsbeginn auf einen potenziell schweren Krankheitsverlauf ein. Dies haben Forschende der Technischen Universität München (TUM) und von Helmholtz Munich herausgefunden. Das Team konnte zeigen, dass der Körper zu Beginn unkomplizierter Erkrankungen auch spezielle T-Zellen bildet, die bislang nur bei chronischen, schweren Infektionen und in Tumoren nachgewiesen worden waren.
-
AATec Medical Secures EUR 4 Million to Advance Lead Respiratory Drug Candidate to Clinical Development
24.04.2025Funding from SPRIND and Family Offices accelerates preparation of ATL-105 for clinical development in lead indication non-CF related bronchiectasis by 2026
-
AATec Medical Secures EUR 4 Million to Advance Lead Respiratory Drug Candidate to Clinical Development
22.04.2025AATec Medical GmbH (AATec), a biotech company developing a multi-product platform for the treatment of respiratory diseases based on recombinant alpha-1 antitrypsin (AAT), today announced that it has secured EUR 4 million in a pre-series A financing from Germany’s Federal Agency for Disruptive Innovation (SPRIND) and high-net worth individuals investors, industry experts and single family offices.
-
Chemeleon to Collaborate with Mayo Clinic to Finalize Ultra-Rapid Assay, Opens $10M Series A
23.04.2025Chemeleon, a disruptive innovator in diagnostic technology, today announced a collaboration with Mayo Clinic to complete development and clinical validation of their ultra-rapid, instrument-free assay poised to redefine point-of-care (POC) testing in emergency settings. This collaboration will focus on clinical optimization of Chemeleon’s flagship high-sensitivity cardiac troponin (hs-cTn) assay and explore the application of their platform technology to other acute care conditions beyond cardiac care. Coinciding with this milestone, the company has opened a $10M Series A funding round to help bring this transformative technology to market.
-
Chemeleon to Collaborate with Mayo Clinic to Finalize Ultra-Rapid Assay, Opens $10M Series A
24.04.2025Chemeleon, a disruptive innovator in diagnostic technology, today announced a collaboration with Mayo Clinic to complete development and clinical validation of their ultra-rapid, instrument-free assay poised to redefine point-of-care (POC) testing in emergency settings. This collaboration will focus on clinical optimization of Chemeleon’s flagship high-sensitivity cardiac troponin (hs-cTn) assay and explore the application of their platform technology to other acute care conditions beyond cardiac care. Coinciding with this milestone, the company has opened a $10M Series A funding round to help bring this transformative technology to market.
-
Eleva Publishes Evidence of Immunomodulation and Neuroprotection Using its Factor H Biological Therapy in Preclinical Dry AMD Study
28.04.2025Eleva, a pioneer in discovering and developing previously inaccessible biologics based on a breakthrough technology platform, announced today the publication of...
-
Eleva Publishes Evidence of Immunomodulation and Neuroprotection Using its Factor H Biological Therapy in Preclinical Dry AMD Study
23.04.2025Eleva, a pioneer in discovering and developing previously inaccessible biologics based on a breakthrough technology platform, announced today the publication of...
-
CCL Faubel feiert 170-jähriges Jubiläum
16.04.2025Dank kleiner Etiketten mit großem Inhalt wurde aus dem Melsunger Unternehmen ein Global Player.
-
STERILINE VERSTÄRKT AUF DER PHARMINTECH 2025 IHRE MARKTPRÄSENZ UND ZEIGT EINE KOMPAKTE MASCHINE, DIE DURCH AGILITÄT UND FLEXIBILITÄT BESTICHT
24.04.2025Steriline, ein hoch spezialisiertes Unternehmen, das auf die Herstellung von Komplettlinien für die aseptische Verpackung von injizierbaren und ophthalmischen Produkten für...
-
Capricorn Scientific and florabio Join Forces to Revolutionize Cell Culture Media in Biotech and Vaccine Industry with Animal-Free, High-Yield Solutions
23.04.2025Capricorn Scientific GmbH, a leading provider of sterile cell culture media and animal-free powders for the biotech and diagnostics industries, proudly announces an...
Sie sehen Artikel 19781 bis 19790 von insgesamt 19830
- Erste Seite
- 1977
- 1978
- 1979
- 1980
- 1981
- Letzte Seite
